DISEASE INDICATIONS: Risk of cardiovascular events
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Entresto is a medication used to treat congestive heart failure, combining sacubitril and valsartan. It works by boosting peptides that dilate blood vessels and promoting sodium excretion, reducing heart failure’s progression and improving outcomes. Clinical studies show Entresto is effective in improving quality of life, cardiovascular outcomes, exercise tolerance, and symptoms of heart failure.